Mahmoud Mohamed Farag Ali
1 clinical trials · Sponsor
◉ Watch Mahmoud Mohamed Farag Ali
| Record | Firm | Date |
|---|---|---|
| Comparative Efficacy and Safety if Intravesical Botulinum Toxin A Versus Platelet-Rich Plasma in the Management of Refractory Overactive Bladder : A 2 Year Study (NCT07693192) | Mahmoud Mohamed Farag Ali | 2026-06-01 |
Track Mahmoud Mohamed Farag Ali automatically
Every clearance here is in the API, with alerts when new ones post.